Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 03, 2023 at 04:18 pm EDT
Longboard Pharmaceuticals, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 15 million compared to USD 11.41 million a year ago. Basic loss per share from continuing operations was USD 0.65 compared to USD 0.67 a year ago. Diluted loss per share from continuing operations was USD 0.65 compared to USD 0.67 a year ago.
For the six months, net loss was USD 26.46 million compared to USD 21 million a year ago. Basic loss per share from continuing operations was USD 1.22 compared to USD 1.23 a year ago. Diluted loss per share from continuing operations was USD 1.22 compared to USD 1.23 a year ago.